This study is for people with Primary Biliary Cholangitis (PBC) who are either starting or already taking elafibranor. The goal is to learn more about how elafibranor works in real-life settings and how it may affect your health and quality of life. You won't receive any treatment as part of the study, and your regular care will not be changed. We'll collect information from your medical records and ask you to complete online surveys about your well-being. If you have a caregiver, they may also be invited to take part by filling out a short survey.
Subjects will continue to receive treatment from primary provider. Provider and patient will work with study team to have relevant health data collected from each visit. Additionally, subjects will need to complete monthly questionnaires regarding their health and quality of life.
Information provided upon request
100% Remote (online, phone, text)
Neil Shah
Center for Gastrointestinal Biology and Disease
Clinical or Medical
Registry
Chronic Conditions
Kidneys and Liver
25-2018
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
